Weiss Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Weiss Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,872,902	Closed	-$56M	–	717
2026 Q1	$56M	Buy	3,872,902 +1,980,105	+105%	+$28.4M	0.94%	21
2025 Q4	$27M	Buy	+1,892,797	New	+$18.6M	0.36%	55

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Weiss Asset Management's FOLD Position: Q2 2026 in Review

Weiss Asset Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 3,872,902 shares — an estimated $56M sold.

Weiss Asset Management first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $56M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Weiss Asset Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Weiss Asset Management sold 3,872,902 Amicus Therapeutics shares in Q2 2026, an estimated $56M.
Weiss Asset Management first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
Weiss Asset Management's Amicus Therapeutics position peaked at $56M in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.